Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech has submitted a disclosure to the stock exchanges under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30). Regulation 30 requires listed companies to inform exchanges about material events or developments that could affect share price or shareholder decisions. The specific contents of this intimation (such as order wins, capacity expansions, leadership changes, or financial results) are not visible in the headline alone. Investors should check the full filing on the NSE/BSE corporate announcements page for exact details. Without the document body, key numbers and specifics cannot be confirmed here.
Regulation 30 intimation covers material events, so the underlying news could be neutral, positive, or negative depending on what was disclosed. Shareholders should review the full filing before drawing conclusions on stock price impact.